Edward S Kim
5PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 25, 2022
Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition.Jay M Lee, Masahiro Tsuboi, Edward S Kim
|Apr 15, 2021
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations.Edward S Kim, Barbara Melosky, Keunchil Park
|Mar 02, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design.Pilar Garrido, Jean-Louis Pujol, Edward S Kim
|Feb 11, 2021
ALTA-2: Phase II study of brigatinib in patients with ALK-positive, advanced non-small-cell lung cancer who progressed on alectinib or ceritinib.Edward S Kim, Fabrice Barlesi, Tony Mok
|Nov 10, 2017
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.Monique B Nilsson, Huiying Sun, Lixia Diao
Pageof 1
Frequent Collaborators
2 joint publications
Tony Sk Mok
2 joint publications
Masahiro Tsuboi
2 joint publications
Pilar Garrido
1 joint publications
Jay M Lee
1 joint publications
Huiying Sun
1 joint publications
Lixia Diao
1 joint publications
Diane Liu
1 joint publications
Alissa Poteete
1 joint publications
Seung-Oe Lim
1 joint publications
Lecia V Sequist
